# Metformin for the Prevention of CRA Recurrence

> **NCT04885426** · NA · UNKNOWN · sponsor: **Jing-yuan Fang, MD, Ph. D** · enrollment: 414 (estimated)

## Conditions studied

- Colorectal Adenoma
- Metformin
- Chemoprevention

## Interventions

- **DRUG:** low-dose metformin
- **DRUG:** high-dose metformin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04885426
- **Lead sponsor:** Jing-yuan Fang, MD, Ph. D
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-08-01
- **Primary completion:** 2022-11
- **Final completion:** 2022-11
- **Target enrollment:** 414 (ESTIMATED)
- **Last updated:** 2021-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04885426

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04885426, "Metformin for the Prevention of CRA Recurrence". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04885426. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*